Cher ML - Search Results

1

Cellular proliferative fraction of metastatic lymph nodes predicts survival in stage D1 (TxN+M0) prostate cancer.

Cher ML, Stephenson RA, James BC, Carroll PR. Cher ML, et al. J Urol. 1996 May;155(5):1674-7. J Urol. 1996. PMID: 8627851

2

Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growth.

Govindarajan B, Sbrissa D, Pressprich M, Kim S, Rishi AK, Vaishampayan U, Cher ML, Chinni SR. Govindarajan B, et al. Among authors: cher ml. Sci Rep. 2023 Nov 23;13(1):20634. doi: 10.1038/s41598-023-47633-4. Sci Rep. 2023. PMID: 37996444 Free PMC article.

3

Upgrading on Per Protocol versus For Cause surveillance prostate biopsies: An opportunity to decreasing the burden of active surveillance.

Wang M, Lange A, Perlman D, Qi J, George AK, Ferrante S, Semerjian A, Sarle R, Cher ML, Ginsburg KB; Michigan Urological Surgery Improvement Collaborative. Wang M, et al. Among authors: cher ml. Prostate. 2023 Sep;83(12):1141-1149. doi: 10.1002/pros.24556. Epub 2023 May 12. Prostate. 2023. PMID: 37173808

4

Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growth.

Govindarajan B, Sbrissa D, Pressprich M, Kim S, Vaishampayan U, Cher ML, Chinni S. Govindarajan B, et al. Among authors: cher ml. Res Sq [Preprint]. 2023 Feb 23:rs.3.rs-2590830. doi: 10.21203/rs.3.rs-2590830/v1. Res Sq. 2023. Update in: Sci Rep. 2023 Nov 23;13(1):20634. doi: 10.1038/s41598-023-47633-4 PMID: 36865146 Free PMC article. Updated. Preprint.

5

Determinants of active surveillance uptake in a diverse population-based cohort of men with low-risk prostate cancer: The Treatment Options in Prostate Cancer Study (TOPCS).

Xu J, Bock CH, Janisse J, Woo J, Cher ML, Ginsburg K, Yacoub R, Goodman M. Xu J, et al. Among authors: cher ml. Cancer. 2024 May 15;130(10):1797-1806. doi: 10.1002/cncr.35190. Epub 2024 Jan 22. Cancer. 2024. PMID: 38247317

6

Screening for prostate cancer.

Cher ML, Carroll PR. Cher ML, et al. West J Med. 1994 Mar;160(3):250. West J Med. 1994. PMID: 7514824 Free PMC article. No abstract available.

7

Screening for prostate cancer.

Cher ML, Carroll PR. Cher ML, et al. West J Med. 1995 Mar;162(3):235-42. West J Med. 1995. PMID: 7536993 Free PMC article. Review.

8

High failure rate associated with long-term follow-up of neoadjuvant androgen deprivation followed by radical prostatectomy for stage C prostatic cancer.

Cher ML, Shinohara K, Breslin S, Vapnek J, Carroll PR. Cher ML, et al. Br J Urol. 1995 Jun;75(6):771-7. doi: 10.1111/j.1464-410x.1995.tb07389.x. Br J Urol. 1995. PMID: 7542137 Clinical Trial.

9

The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy.

Wolf JS Jr, Cher M, Dall'era M, Presti JC Jr, Hricak H, Carroll PR. Wolf JS Jr, et al. J Urol. 1995 Mar;153(3 Pt 2):993-9. J Urol. 1995. PMID: 7853590 Review.

10

Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression.

Cher ML, Chew K, Rosenau W, Carroll PR. Cher ML, et al. Prostate. 1995 Feb;26(2):87-93. doi: 10.1002/pros.2990260205. Prostate. 1995. PMID: 7855002

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters